BeiGene gets China NMPA approval for Tislelizumab to treat certain solid tumours
The NMPA approval was based on positive results from a single-arm, multi-centre, open-label Phase 2 trial that evaluated…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Mar 22
The NMPA approval was based on positive results from a single-arm, multi-centre, open-label Phase 2 trial that evaluated…
11 Mar 22
Xcellomics programme was created by the two Oxford-based institutions to advance the early-stage drug discovery research by academic…
11 Mar 22
The recalled devices include certain ventilators and continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP)…
10 Mar 22
Doctors continue to experiment with the potential health benefits of CBD. We hear from experts about how the…
10 Mar 22
The Phase 2/3 EPIC-PEDS study is designed to enrol around 140 paediatric participants, aged below 18 years of…
10 Mar 22
Nitroglycerin sublingual tablet is used to relieve episodes of chest pain, called angina, in people with coronary artery…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Mar 22
The companies will advance the development of FixVac and Libtayo to treat advanced NSCLC, expanding their existing partnership…
09 Mar 22
Novartis can access Voyager’s AAV capsids for use in therapies for three central nervous system diseases, with options…
08 Mar 22
The company has also announced its public health strategy, which targets the prevention of infectious diseases by advancing…
08 Mar 22
The new site will use new technologies to enhance the efficiency and capability to produce a wide range…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates